الإرشاد الصحي العالمي
تعمل خدمة الإرشاد بمؤسسة إل جي بي على تنسيق جميع احتياجاتك الطبية منذ استشارتك الأولى، وتوفر لك إعادة التأمين خلال فترة علاجك.
تقع المؤسسة في شارع هارلي العريق بمدينة لندن وتدير شبكة تغطي كل من لوس أنجلوس، وهونج كونج، ودبي، وتقدم خدمة الإرشاد الصحي بقيادة أطباء للأشخاص الأثرياء والمؤسسات التجارية.
تقع المؤسسة في شارع هارلي العريق بمدينة لندن وتدير شبكة تغطي كل من لوس أنجلوس، وهونج كونج، ودبي، وتقدم خدمة الإرشاد الصحي بقيادة أطباء للأشخاص الأثرياء والمؤسسات التجارية.
الرعاية الموَّحدة
إذا كنت تقضي مع أسرتك شهور عديدة في الخارج بسبب ارتباطات العمل و/أو بسبب امتلاك منزل ثانٍ في الخارج، تستطيع مؤسسة لندن جنرال براكتيس أن تساعدك في التواصل مع أفضل الأطباء في المدن الرئيسية بجميع أنحاء العالم.
ونظرًا لأن المؤسسة ترتبط بعلاقات قوية خاصة في الولايات المتحدة (مثل نيويورك، وبوسطن، ولوس أنجلوس، وميامي)، بالإضافة إلى هونج كونج والعديد من المدن الأوروبية الرئيسية، فإنها بصدد توسيع شبكتها لتشمل أقاليم أسيوية أخرى إلى جانب آسيا الجنوبية.
لمعرفة المزيد من المعلومات عن خدماتنا، أو لحجز استشارة مع أحد الممارسين العموميين لدينا، اتصل على الرقم 1000 935 0207
للحصول على خدمة الزيارات المنزلية يوميًا على مدار الساعة، اتصل على الرقم 1000 935 207(0) 44+.
Closed
Genetic Testing for Cancer
The panel determines whether you are at an increased risk to develop more than 57 inherited conditions, including:
- Breast cancer
- Colorectal (bowel) cancer
- Cutaneous melanoma
- Gastric cancer
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Renal cell cancer
- Thyroid cancer
- Uterine cancer
- Additional hereditary cancer conditions
The full list of genes tested for and their related condition is below:
Gene(s) | Condition(s) | |
APC | Colorectal, endocrine, gastric, nervous system/brain, and pancreatic cancer, sarcoma | |
ATM | Breast, pancreatic, and prostate cancer | |
AXIN2 | Colorectal cancer | |
BAP1 | Renal/urinary tract cancer, melanoma | |
BARD1 | Breast cancer | |
BMPR1A | Colorectal, gastric, and pancreatic cancer | |
BRCA1 | Breast, gynaecologic, pancreatic, and prostate cancer | |
BRCA2 | Breast, gynaecologic, pancreatic, and prostate cancer, melanoma | |
BRIP1 | Breast and gynaecologic cancer | |
CDC73 | Endocrine and renal/urinary tract cancer | |
CDH1 | Breast, colorectal, and gastric cancer | |
CDK4 | Melanoma | |
CDKN2A | Nervous system/brain and pancreatic cancer, melanoma | |
CHEK2 | Breast, colorectal, endocrine, gynaecologic, and prostate cancer | |
DICER1 | Endocrine, gynaecologic, nervous system/brain, and renal/ urinary tract cancer, sarcoma | |
EPCAM | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
FH | Renal/urinary tract cancer, sarcoma | |
FLCN | Renal/urinary tract cancer | |
GREM1 | Colorectal cancer | |
HOXB13 | Prostate cancer | |
KIT | Gastric cancer, sarcoma | |
MAX | Endocrine cancer | |
MEN1 | Endocrine, nervous system/brain, and pancreatic cancer | |
MET | Renal/urinary tract cancer | |
MITF | Melanoma | |
MLH1 | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
MSH2 | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
MSH3 | Colorectal cancer, includes reporting of carrier status | |
MSH6 | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
MUTYH | Colorectal cancer | |
NBN | Breast and prostate cancer | |
NF1 | Breast, endocrine, gastric, and nervous system/brain cancer | |
NF2 | Nervous system/brain cancer | |
NTHL1 | Colorectal cancer, includes reporting of carrier status | |
PALB2 | Breast and pancreatic cancer | |
PDGFRA | Gastric cancer, sarcoma | |
PMS2 | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
POLD1 | Colorectal cancer | |
POLE | Colorectal cancer | |
PRKAR1A | Endocrine and nervous system/brain cancer, sarcoma | |
PTCH1 | Nervous system/brain and skin cancer, sarcoma | |
PTEN | Breast, colorectal, endocrine, gynaecologic, nervous system/brain and, renal/urinary tract cancer, melanoma | |
RAD51C | Breast and gynaecologic cancer | |
RAD51D | Breast and gynaecologic cancer | |
RB1 | Melanoma, retinoblastoma, sarcoma | |
RET | Endocrine cancer | |
SDHA | Endocrine and gastric cancer, sarcoma | |
SDHAF2 | Endocrine cancer | |
SDHB | Endocrine, gastric, and renal/urinary tract cancer, sarcoma | |
SDHC | Endocrine, gastric, and renal/urinary tract cancer, sarcoma | |
SDHD | Endocrine, gastric, and renal/urinary tract cancer, sarcoma | |
SMAD4 | Colorectal, gastric, and pancreatic cancer | |
SMARCA4 | Gynaecologic cancer | |
SMARCB1 | Nervous system/brain and renal/urinary tract cancer | |
STK11 | Breast, colorectal, gastric, gynaecologic, and pancreatic cancer | |
TMEM127 | Endocrine cancer | |
TP53 | Breast, endocrine, gastrointestinal, genitourinary, gynaecologic, hematologic, nervous system/brain, and skin cancer, sarcoma | |
TSC1 | Nervous system/brain, pancreatic, and renal/urinary tract cancer | |
TSC2 | Nervous system/brain, pancreatic, and renal/urinary tract cancer | |
VHL | Endocrine, nervous system/brain, pancreatic, and renal/urinary tract cancer | |
WT1 | Renal/urinary tract cancer |
Cardiovascular Genetic Testing
The panel determines whether you are at an increased risk to develop more than 45 inherited conditions, including:
- Aortopathies
- Arrhythmias
- Cardiomyopathies
- Genetic forms of high blood pressure and
high cholesterol - Thrombophilia
- Additional hereditary cardiovascular conditions
The full list of genes tested for and their related condition is below:
Gene(s) | Condition(s) | |
ACTA2 | Aortopathy | |
ACTC1 | Cardiomyopathy, congenital heart disease | |
ACTN2 | Arrhythmia, cardiomyopathy | |
ACVRL1 | Hereditary hemorrhagic telangiectasia, pulmonary arterial hypertension | |
APOB | Familial hypercholesterolemia, familial hypobetalipoproteinemia | |
BAG3 | Cardiomyopathy, neuromuscular condition | |
BMPR2 | Pulmonary arterial hypertension | |
CACNA1C | Arrhythmia, cardiomyopathy, congenital heart disease | |
CACNB2 | Arrhythmia | |
CALM1 | Arrhythmia | |
CALM2 | Arrhythmia | |
CALM3 | Arrhythmia | |
CASQ2 | Arrhythmia, includes reporting of carrier status | |
CAV1 | Pulmonary arterial hypertension | |
CAV3 | Arrhythmia, cardiomyopathy, neuromuscular condition | |
COL3A1 | Aortopathy | |
CRYAB | Cardiomyopathy, neuromuscular condition | |
CSRP3 | Cardiomyopathy | |
DES | Arrhythmia, cardiomyopathy, neuromuscular condition | |
DMD | Cardiomyopathy, neuromuscular condition | |
DSC2 | Arrhythmia, cardiomyopathy | |
DSG2 | Arrhythmia, cardiomyopathy | |
DSP | Arrhythmia, cardiomyopathy | |
EMD | Arrhythmia, cardiomyopathy, neuromuscular condition | |
ENG | Hereditary hemorrhagic telangiectasia, pulmonary arterial hypertension | |
F2 | Hereditary thrombophilia | |
F5 | Hereditary thrombophilia | |
F9 | Hemophilia, hereditary thrombophilia | |
FBN1 | Aortopathy | |
FHL1 | Cardiomyopathy, neuromuscular condition | |
FLNC | Cardiomyopathy, neuromuscular condition | |
GDF2 | Hereditary hemorrhagic telangiectasia | |
GLA | Cardiomyopathy, lysosomal storage disease | |
GPD1L | Arrhythmia | |
HCN4 | Arrhythmia, cardiomyopathy | |
JUP | Arrhythmia, cardiomyopathy | |
KCNE1 | Arrhythmia | |
KCNE2 | Arrhythmia | |
KCNH2 | Arrhythmia | |
KCNJ2 | Arrhythmia | |
KCNQ1 | Arrhythmia | |
LAMP2 | Cardiomyopathy, glycogen storage disease | |
LDLR | Familial hypercholesterolemia | |
LDLRAP1 | Familial hypercholesterolemia, includes reporting of carrier status | |
LMNA | Arrhythmia, cardiomyopathy, neuromuscular condition | |
MYBPC3 | Cardiomyopathy | |
MYH11 | Aortopathy | |
MYH7 | Cardiomyopathy, neuromuscular condition | |
MYL2 | Cardiomyopathy | |
MYL3 | Cardiomyopathy | |
MYLK | Aortopathy | |
NKX2-5 | Arrhythmia, congenital heart disease | |
PCSK9 | Familial hypercholesterolemia | |
PKP2 | Arrhythmia, cardiomyopathy | |
PLN | Arrhythmia, cardiomyopathy | |
PRKAG2 | Arrhythmia, cardiomyopathy | |
PRKG1 | Aortopathy | |
PROC | Hereditary thrombophilia | |
PROS1 | Hereditary thrombophilia | |
RBM20 | Arrhythmia, cardiomyopathy | |
RYR2 | Arrhythmia, cardiomyopathy | |
SCN5A | Arrhythmia, cardiomyopathy | |
SERPINC1 | Hereditary thrombophilia | |
SGCD | Cardiomyopathy, neuromuscular condition | |
SMAD3 | Aortopathy | |
SMAD4 | Hereditary hemorrhagic telangiectasia | |
TCAP | Cardiomyopathy, neuromuscular condition | |
TGFB2 | Aortopathy | |
TGFB3 | Aortopathy, arrhythmia, cardiomyopathy | |
TGFBR1 | Aortopathy, multiple self-healing squamous epithelioma | |
TGFBR2 | Aortopathy | |
TMEM43 | Arrhythmia, cardiomyopathy | |
TNNC1 | Cardiomyopathy | |
TNNI3 | Arrhythmia, cardiomyopathy | |
TNNT2 | Arrhythmia, cardiomyopathy | |
TPM1 | Cardiomyopathy | |
VCL | Cardiomyopathy |
Combined Genetic Testing
When we test for cancer and cardiomyopathy combined we also screen for the following metabolic disorders:
Gene(s) | Condition(s) | |
ATP7B | Wilson disease, includes reporting of carrier status | |
CACNA1S | Hypokalemic periodic paralysis, malignant hyperthermia susceptibility | |
HAMP | Hereditary hemochromatosis, includes reporting of carrier status | |
HFE | Hereditary hemochromatosis, includes reporting of carrier status | |
HJV | Hereditary hemochromatosis, includes reporting of carrier status | |
OTC | Ornithine transcarbamylase deficiency | |
RYR1 | Malignant hyperthermia susceptibility, neuromuscular condition | |
SERPINA1 | Alpha-1 antitrypsin deficiency, includes reporting of carrier status | |
SLC40A1 | Hereditary hemochromatosis | |
TFR2 | Hereditary hemochromatosis, includes reporting of carrier status |